Liminatus Pharma LIMN
NASDAQ LIMN
$3.96 +0.05 (+1.28%)
As of: Sep 30, 2026 · 2:05 PM EDT

Liminatus Pharma, Inc. (LIMN) Retained Earnings (2024 - 2026)

Updated

Liminatus Pharma (LIMN) recorded Retained Earnings of -$41.4 million in Q2 2026, compared with -$28.88 million a year earlier.

Analysis

Liminatus Pharma, Inc. (LIMN) Retained Earnings (2024 - 2026) Analysis & Trends

At the end of FY2025, Liminatus Pharma reported Retained Earnings of -$38.87 million.

  • Across earlier years, Retained Earnings came in at -$28.67 million in FY2024.
  • Per Business Quant, the preceding three quarters came in at -$40 million (Q1 2026), -$38.87 million (Q4 2025) and -$30.7 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -41.40 Mn
Mar 31, 2026 -40.00 Mn
Dec 31, 2025 -38.87 Mn
Sep 30, 2025 -30.70 Mn
Jun 30, 2025 -28.88 Mn
Mar 31, 2025 -1,060.00
Dec 31, 2024 -28.67 Mn
API Access

Liminatus Pharma, Inc. Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=LIMN&period=max&api_key=YOUR_API_KEY